Department of Internal Medicine, Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.
Department of Radiology, Healthcare Research Institute, Healthcare System Gangnam Center, Seoul National University Hospital, Seoul, Korea.
Dig Liver Dis. 2019 Jul;51(7):1030-1035. doi: 10.1016/j.dld.2018.12.024. Epub 2019 Jan 9.
Growing evidence supports that nonalcoholic fatty liver disease (NAFLD) is associated with extrahepatic cancers. Nonalcoholic fatty liver disease (NAFLD) and breast cancer share similar risk factors, including obesity.
The aim of this case-control study was to investigate the association between NAFLD and breast cancer.
Subjects who received health screening, including mammography and breast and hepatic ultrasonography simultaneously, were included. Subjects diagnosed with breast cancer were matched with controls. Conditional logistic regression analyses were performed.
Among 270 breast cancer patients and 270 controls, 81 cancer patients (30.0%) and 54 controls (20.0%) had NAFLD (P = 0.008). NAFLD was significantly associated with breast cancer in multivariate analysis (P = 0.046). When the interaction between obesity (BMI < 25 kg/m vs. ≥25 kg/m) and NAFLD in breast cancer patients was examined, a significant effect modification between obesity and NAFLD in breast cancer was noted (P = 0.021). The subgroup analysis showed that NAFLD was significantly associated with breast cancer in the nonobese subgroup (odds ratio 3.04, 95% confidence interval 1.37-4.32, P = 0.002) but not in the obese group (P = 0.163).
NAFLD was significantly associated with breast cancer independent of traditional risk factors, and this association existed in the nonobese subgroup but not in the obese subgroup.
越来越多的证据表明,非酒精性脂肪性肝病(NAFLD)与肝外癌症有关。非酒精性脂肪性肝病(NAFLD)和乳腺癌有相似的危险因素,包括肥胖。
本病例对照研究旨在探讨 NAFLD 与乳腺癌之间的关系。
纳入同时接受乳腺 X 线摄影和乳腺及肝脏超声检查的健康筛查受试者。将诊断为乳腺癌的患者与对照组进行匹配。采用条件逻辑回归分析。
在 270 例乳腺癌患者和 270 例对照中,81 例癌症患者(30.0%)和 54 例对照(20.0%)患有 NAFLD(P=0.008)。多变量分析显示,NAFLD 与乳腺癌显著相关(P=0.046)。当在乳腺癌患者中检查肥胖(BMI<25kg/m 与≥25kg/m)和 NAFLD 之间的交互作用时,注意到肥胖和乳腺癌中 NAFLD 之间存在显著的效应修饰(P=0.021)。亚组分析显示,NAFLD 与非肥胖亚组的乳腺癌显著相关(比值比 3.04,95%置信区间 1.37-4.32,P=0.002),但与肥胖组无关(P=0.163)。
NAFLD 与乳腺癌显著相关,独立于传统危险因素,这种关联存在于非肥胖亚组,但不存在于肥胖亚组。